1.37 USD
↗ 0.00 (0.00%)LIVE (AS OF 02:01 PM EDT)
Talphera, Inc. Common Stock
TLPHNASDAQ • USD
Market: OPEN
Talphera, Inc. Common Stock (TLPH) is currently trading at $1.37. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, TLPH trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Jul 23, 2026.
Open?$1.40
High?$1.48
Low?$1.33
Prev. Close?$1.37
Volume?79.4K
Avg. Volume?403.0K
VWAP?$1.37
Rel. Volume?0.20x
Bid / Ask
Bid?$1.16 × 100
Ask?$1.38 × 100
Spread?$0.22
Midpoint?$1.27
Valuation & Ratios
Market Cap?71.1M
Shares Out?51.9M
Float?29.5M
Float %?56.8%
P/E Ratio?N/A
P/B Ratio?3.85
EPS?-$0.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Employees
12
Market Cap
67.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2011-02-11
Address
1850 GATEWAY DRIVE
SAN MATEO, CA 94404
Phone: 650-216-3500
SAN MATEO, CA 94404
Phone: 650-216-3500
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?74
Piotroski F-Score?0/9Weak
Altman Z-Score?-19.49Distress
Confidence?42%Low
Short InterestLow
Short % of Float?1.91%Low
Short Interest?562.6K
Days to Cover?1.7
Free Float29.5M
Avg Daily Volume329.5K
Settlement Date2026-06-30
Financial Health
Current Ratio?2.16Strong
Quick Ratio?2.16Strong
Cash Ratio?0.39Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?3.85FAIR▾
Peers100
S&P46
P/S?71,102.52HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-4.6CHEAP▾
S&P97
EV/Sales?67,279.52HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-77.1%WEAK▾
S&P3
ROA?-47.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$67.3M
Fundamentals ratios updated end of day